Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Boston Scientific

Close the acquisition of Baylis Medical Company Inc

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
6 Oct 2021
Due
31 Mar 2022
Delivered
14 Feb 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is anticipated to close in the first quarter of 2022, subject to customary closing conditions”

What we found

Evidence strength A What the grades mean

The filings state the Baylis Medical acquisition was completed on February 14, 2022, before the first-quarter 2022 deadline.

  • A
    Boston Scientific 10-Q filed 2022-05-05 Regulatory filing · published 5 May 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint f9c1b47348a1
    “On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company” ✓ confirmed on the page
  • A
    Boston Scientific 10-Q filed 2022-08-04 Regulatory filing · published 4 Aug 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 6250a9ed854d
    “On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical)” ✓ confirmed on the page

Market reaction: the shares moved -3.2% against the S&P 500 over the three sessions around the disclosure (4 May 2022 to 9 May 2022). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
acquisition of Baylis Medical Company Inc.
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to customary closing conditions
Depends on
Regulatory, Counterparty

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Boston Scientific? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-BSX-005393 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.